Taylor Swift's Christmas card is here—and this is what it looks like President Trump signs executive order reclassifying marijuana Safety concerns grow after reported midair close call Self-made ...

BioMarin BMRN0.75%increase; green up pointing triangle Pharmaceutical has struck a deal to buy fellow biotech Amicus Therapeutics FOLD-0.07%decrease; red down pointing triangle for about $4.8 billion ...

GSK is embarking on a journey with CAMP4 Therapeutics, paying $17.5 million upfront to collaborate on regulatory RNA-targeting therapeutics in neurodegenerative and kidney disease indications. CAMP4 ...

Amid news of the splashy $4.8 billion Amicus buy, BioMarin has slipped in the discontinuation of a genetic liver disease candidate it had once hoped would become a best-in-class treatment. The oral ...

The last time Sam Darnold faced the Los Angeles Rams, he had a flashback to his "seeing ghosts" days, tossing four interceptions for the first time since 2019 with the New York Jets. In the Seahawks' ...

‘These technologies enter the market without proper qualification,’ Gebhardt says. Image: Fraunhofer ISE This interview appears alongside others on module reliability in the latest edition of our ...

(KRON) — French biotechnology company bioMérieux, Inc. plans to lay off 121 employees and permanently close its South Bay facility, according to a state filing. The company disclosed the cuts in a ...

No. 5 Oregon opened as a 1½-point over No. 4 Texas Tech for their January 1 College Football Playoff quarterfinal in the Orange Bowl. The Ducks head into the New Year’s Day game off a 51-34 win over ...

BioMarin Pharmaceutical has struck a deal to buy fellow biotech Amicus Therapeutics for about $4.8 billion in cash, expanding the company’s portfolio in treatments for rare diseases. BioMarin on ...

Sam Leavitt will be a heavily coveted player coming out of the transfer portal and is already being linked to several P4 programs. The former Sun Devils signal caller played at a high level each of ...